secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2026-06-08T20:05:07+00:00
Accession:  0001104659-26-071364
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Capricor shareholders fail to approve officer exculpation amendment at annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected; Linda Marbán, Ph.D. re-elected with 25.5M votes for.
- Ratification of Rose, Snyder & Jacobs LLP as auditor passed with 43.1M votes for.
- Advisory vote on executive compensation approved (24.3M for, 6.2M against).
- Non-binding vote favored '1 Year' frequency for future say-on-pay votes (29.8M of votes cast).
- Amendment to certificate for officer exculpation failed: 23.5M for, 6.4M against, 13M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000110465926071364/0001104659-26-071364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000110465926071364/capr-20260604x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer